Gensulin (Human Insulin)
Diabetes Mellitus
ApprovedActive
Key Facts
About Bioton
Bioton is an established, commercial-stage Polish biotech company with a strategic focus on diabetes care, primarily through its flagship biosimilar insulin product, Gensulin. The company has a fully integrated model encompassing R&D, manufacturing, and commercialization, with a significant presence in its home market and international operations. Its business is built on providing affordable, complex therapeutic solutions for diabetes, supported by patient education and digital health initiatives.
View full company profileTherapeutic Areas
Other Diabetes Mellitus Drugs
| Drug | Company | Phase |
|---|---|---|
| Insulin Aspart Biosimilar | USV Biologics Division | Commercial |
| Sirolimus-Coated Balloon (SCB) - DEDICATE Registry | Concept Medical | Registry |
| Insulin Biosimilars Portfolio | GEROPHARM | Approved/Commercial |
| Biosimilar Insulin Glargine | Wockhardt | Launched |
| Biosimilar Insulin Aspart | Wockhardt | Launched |
| Human Insulin | EVA Pharma | Approved |
| Insulin Glargine | Biomm | Approved |
| Insulin Analog Formulations | RPG Life Sciences | ANDA Filed/Development |